Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 60
- Locations
- 2
- Primary Endpoint
- Sniff diaphragm thickening fraction
Study Overview
Brief Summary
This study is investigating the normal range of maximal diaphragm thickness during a sniff inspiratory manoeuvre using ultrasound in healthy subjects stratified by age and gender.
Detailed Description
Diaphragm dysfunction is associated with poor clinical outcomes in critically ill patients but is difficult to diagnose. Traditionally, diaphragm function is measured by evaluating inspiratory muscle strength via maximal inspiratory pressure (MIP). However, this technique relies on a volitional maximal effort and can be challenging for patients to perform.
An alternative to measuring inspiratory muscle strength is the sniff inspiratory pressure approach. During short, sharp sniffs, the diaphragm is maximally activated.
Currently, there are no reported values of the normal range of maximal diaphragm thickness during a sniff maneuver. This study will define the normal range of values for sniff maximal diaphragm thickening fraction, maximal thickening against an occluded airway, and diaphragm thickening during resting tidal breathing in healthy subjects.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Over 18 years of age
Exclusion Criteria
- •Antecedent history of neuromuscular or cardiorespiratory disease
Outcomes
Primary Outcomes
Sniff diaphragm thickening fraction
Time Frame: Day 1
Thickening of the diaphragm during an inspiratory sniff
Maximal diaphragm thickening fraction
Time Frame: Day 1
Thickening of the diaphragm during a maximal inspiratory effort
Resting tidal thickening fraction
Time Frame: Day 1
Thickening of the diaphragm during resting tidal breathing
Secondary Outcomes
No secondary outcomes reported
Investigators
Ewan Goligher
Intensivist
University Health Network, Toronto
